Fig. 1

ZBTB9 expression landscape. The expression distribution of ZBTB9 among tumor tissues and normal tissues with TIMER2 (A). The expression level of the ZBTB9 gene was overexpressed in TCGA LIHC patients’ database (374 cancerous tissues and 50 paracancerous tissues) (B), GSE76427 (52 cancerous tissues and 114 paracancerous tissues) (C) and GSE36376 (193 cancerous tissues and 241 paracancerous tissues) (D). IHC of LIHC samples, cancerous tissue (E, G), paracancerous tissue (F, H). The higher expression level of the ZBTB9 gene was detected in the subgroups of female, TP53 mutation, fibrolamellar carcinoma, higher tumor grade, and higher individual cancer stages (I–N). (*p < 0.05; **p < 0.01; ***p < 0.001)